Renal denervation device firm obtains $2.7M

08/16/2013 | (Boston)

Ablative Solutions has secured $2.7 million from 41 undisclosed backers, part of a funding round aiming for $5 million. The company, with offices in Michigan and California, is working on a perivascular renal denervation device that can be used to treat patients with high blood pressure by delivering radio-frequency energy straight to the nerves.

View Full Article in: (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA